Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "KEYNOTE-859 Study of Pembro + Chemo for Advanced HER2- GC/GEJC - Outcomes in the Protocol-Specified PD-L1-Selected Populations"

147 views
July 11, 2023
Comments 0
Login to view comments. Click here to Login